What is the significance of a serum sodium level of 133 mEq/L and a serum osmolality of 272 mOsm/kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The serum sodium level of 133 mEq/L indicates mild hyponatremia, and the serum osmolality of 272 mOsm/kg is also slightly below the normal range, representing hypotonic hyponatremia, where both sodium and osmolality are decreased. This condition requires careful management to prevent complications such as osmotic demyelination syndrome.

Key Considerations

  • The patient's serum sodium level is slightly below the normal range, which may not require immediate correction, but rather monitoring and management of the underlying cause.
  • The serum osmolality is also slightly below the normal range, indicating hypotonic hyponatremia.
  • Potential causes of hyponatremia include excessive water intake, syndrome of inappropriate antidiuretic hormone secretion (SIADH), heart failure, liver disease, kidney disease, or certain medications, as noted in studies such as 1 and 1.

Management

  • For mild, asymptomatic hyponatremia like this, fluid restriction to 1-1.5 liters per day is often the first step, as recommended by guidelines such as 1.
  • If the patient has symptoms (headache, nausea, confusion), closer monitoring is needed, and sodium correction should be gradual, not exceeding 8 mEq/L in 24 hours to prevent osmotic demyelination syndrome, as advised in 1 and 1.
  • Addressing the underlying cause is essential - this might involve discontinuing offending medications, treating heart failure, or managing other conditions.
  • Regular monitoring of serum sodium levels (every 4-6 hours initially) is important to ensure appropriate correction rates.
  • Salt tablets or hypertonic saline may be considered in more severe cases, but are likely unnecessary for this mild presentation, as stated in 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Significance of Serum Sodium and Osmolality Levels

  • A serum sodium level of 133 mEq/L is considered hyponatremic, as it is below the normal range of 135-145 mEq/L 2, 3, 4.
  • A serum osmolality of 272 mOsm/kg is considered hypo-osmolar, as it is below the normal range of 280-300 mOsm/kg 4.
  • The combination of hyponatremia and hypo-osmolality suggests an excess of water in the body relative to sodium, which can be caused by various factors such as heart failure, liver disease, or syndrome of inappropriate antidiuretic hormone secretion (SIADH) 2, 3, 5.

Clinical Implications

  • Hyponatremia is associated with increased hospital stay and mortality, and even mild hyponatremia can cause cognitive impairment, gait disturbances, and increased rates of falls and fractures 2.
  • The severity of symptoms depends on the rapidity of development, duration, and severity of hyponatremia, and can range from mild and nonspecific to severe and life-threatening 2.
  • Evaluation of hyponatremia relies on clinical assessment, estimation of serum sodium, urine electrolytes, and serum and urine osmolality, as well as other case-specific laboratory parameters 6.

Management

  • Treatment of hyponatremia should focus on addressing the underlying cause, and may involve fluid restriction, hypertonic saline, or vasopressin receptor antagonists 2, 3.
  • In patients with severely symptomatic hyponatremia, bolus hypertonic saline may be used to rapidly correct the serum sodium level, but overly rapid correction can cause osmotic demyelination 2.
  • Point-of-care ultrasonography can be an important adjunct to physical assessment in estimating volume status and guiding management of hyponatremia 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The hyponatremic patient: a systematic approach to laboratory diagnosis.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2002

Research

Demystifying hyponatremia: A clinical guide to evaluation and management.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.